P
Paul M. Hassoun
Researcher at Johns Hopkins University
Publications - 308
Citations - 16671
Paul M. Hassoun is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Pulmonary hypertension & Medicine. The author has an hindex of 61, co-authored 267 publications receiving 14372 citations. Previous affiliations of Paul M. Hassoun include Johns Hopkins University School of Medicine.
Papers
More filters
Journal ArticleDOI
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.
Anna R. Hemnes,Jane A. Leopold,Milena Radeva,Gerald J. Beck,Aiden Abidov,Micheala A. Aldred,John Barnard,Erika B. Rosenzweig,Barry A. Borlaug,Wendy K. Chung,Suzy A. A. Comhair,Ankit A. Desai,Hilary M. DuBrock,Serpil C. Erzurum,J. Emanuel Finet,Robert P. Frantz,Joe G.N. Garcia,Mark W. Geraci,Michael P. Gray,Gabriele Grunig,Paul M. Hassoun,Kristin B. Highland,Nicholas S. Hill,Bo Hu,Deborah H Kwon,Miriam Jacob,Christine Jellis,A. Brett Larive,Jason K. Lempel,Bradley A. Maron,Stephen C. Mathai,Kevin McCarthy,Reena Mehra,R Nawabit,John H. Newman,Mitchell A. Olman,Jose A. Ramos,Rahul D. Renapurkar,Franz Rischard,S. G. Sherer,W.H. Wilson Tang,James D. Thomas,Rebecca Vanderpool,Aaron B. Waxman,Jennifer Wilcox,Jason X.-J. Yuan,Evelyn M. Horn +46 more
TL;DR: PVDOMICS as discussed by the authors is a precision medicine initiative to characterize pulmonary vascular disease (PVD) using deep phenotyping and integration of clinical metrics with omic measures will enhance understanding of PVD and facilitate an updated PVD classification.
Journal ArticleDOI
Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates
Majdy M Idrees,Sarfraz Saleemi,M Ali Azem,Saleh Aldammas,Manal Al-Hazmi,Javid Khan,Abdulgafour Gari,Maha M. Al-Dabbagh,Husam Sakkijha,Abdulla Aldalaan,Khalid Alnajashi,Waleed AlHabeeb,Imran Nizami,Amjad Kouatli,May Chehab,Omar Tamimi,Hanaa Banjar,Tarek Kashour,Antonio Augusto Lopes,Omar A. Minai,Paul M. Hassoun,Qadar Pasha,Eckhard Mayer,Ghazwan Butrous,Sastry Bhagavathula,Stefano Ghio,John R. Swiston,Adel Boueiz,Adriano R. Tonelli,Robert D. Levy,Marius M. Hoeper,Rober D Levy +31 more
TL;DR: This Guideline was designed to provide recommendations for problems frequently encountered by practicing clinicians involved in management of PH, and targets mainly adult and pediatric PH-treating physicians, but can also be used by other physicians interested in PH.
Journal ArticleDOI
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension.
Olivier Sitbon,Sylvia Nikkho,Raymond L. Benza,Chunqin Cq Deng,Harrison W. Farber,Mardi Gomberg-Maitland,Paul M. Hassoun,Christian Meier,Joanna Pepke-Zaba,Krishna Prasad,Werner Seeger,Paul A. Corris +11 more
TL;DR: The current understanding of endpoints used in phase 2 and 3 trials for pulmonary hypertension is reviewed and the value of newer approaches are discussed, including the roles of composite endpoints and how these can be developed and validated.
Journal ArticleDOI
Differential gene expression in chronic hypoxic pulmonary hypertension: effect of simvastatin treatment.
Reda E. Girgis,Shwu Fan Ma,Shui Qing Ye,Dmitry N. Grigoryev,Dechun Li,Paul M. Hassoun,Rubin M. Tuder,Roger A. Johns,Joe G.N. Garcia +8 more
Journal ArticleDOI
Bidimensional measurements of right ventricular function for prediction of survival in patients with pulmonary hypertension: comparison of reproducibility and time of analysis with volumetric cardiac magnetic resonance imaging analysis.
Celia P. Corona-Villalobos,Ihab R. Kamel,Neda Rastegar,Rachel L. Damico,Todd M. Kolb,Danielle Boyce,Ala Eddin S. Sager,Jan Skrok,Monda L. Shehata,Jens Vogel-Claussen,David A. Bluemke,Reda E. Girgis,Stephen C. Mathai,Paul M. Hassoun,Stefan L. Zimmerman +14 more
TL;DR: TAPSE <18 mm by CMR was strongly and independently associated with survival in PAH, and TAPSE, RVFS, and RVFAC measures are efficient measures of RV function by C MR that demonstrate significant correlation with invasive measures of PAH severity.